Global Prenatal Testing And Newborn Screening Market Size and Forecast 2023-2032| PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera, Invitae

The Prenatal Testing And Newborn Screening Global Market Report 2023 by The Business Research Company, provides prenatal testing & newborn screening market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Prenatal Testing And Newborn Screening Market:

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

According to The Business Research Company’s Prenatal Testing And Newborn Screening Global Market Report 2023, the market size grew from $5.04 billion in 2022 to $5.65 billion in 2023 at a compound annual growth rate (CAGR) of 12.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The prenatal testing & newborn screening market size is expected to grow from $8.87 billion in 2027 at a CAGR of 11.9%.

The high prevalence of genetic diseases in infants contributed to the growth of the prenatal testing & newborn screening market. According to the World Health Organization, genetic disease includes diseases such as Thalassemia, Sickle Cell Anaemia, Haemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, Huntington’s disease. The sickle cell anaemia is one of the genetic diseases that affects millions throughout the world, and the disease is particularly common among people whose ancestors are from Africa, America, Cuba, Central America, Saudi Arabia, and India.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=3350&type=smp

The prenatal testing & newborn screening market is segmented:

1) By Diagnostic Type: Non-Invasive, Invasive

2) By Technology: Screening Technology, Diagnostic Technology

3) By End user: Hospitals, Diagnostic centers

The use of machine learning and artificial intelligence is gradually gaining popularity in the prenatal testing & newborn screening market. Artificial intelligence (AI) is the simulation of human intelligence in machines. Machine learning is a part of AI. Machine learning and AI help companies in the prenatal testing & newborn screening market to conduct a detailed analysis of all relevant data, provide insights about different diseases, and offer a more accurate evaluation of tissue samples. For instance, In September 2021, Sema4, a US-based AI-driven genomic and clinical data intelligence platform company, launched Sema4 Elements. Sema4 Elements are genetic solutions that are information-driven, digital tools for patients and providers, and services that let doctors manage patients holistically throughout their journeys with reproductive and generational health, using artificial intelligence.

The prenatal testing & newborn screening market report table of contents includes:

1. Executive Summary

2. Prenatal Testing & Newborn Screening Market Characteristics

3. Prenatal Testing & Newborn Screening Market Trends And Strategies

4. Prenatal Testing & Newborn Screening Market – Macro Economic Scenario

5. Prenatal Testing & Newborn Screening Market Size And Growth

26. Africa Prenatal Testing & Newborn Screening Market

27. Prenatal Testing & Newborn Screening Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Prenatal Testing & Newborn Screening Market

29. Prenatal Testing & Newborn Screening Market Future Outlook and Potential Analysis

30. Appendix

Top Major Players: